atosiban: Clinical Trials

4 trials of atosiban, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown, 1 withdrawn. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 1, Terminated 1, Unknown 1, Withdrawn 1

Follow atosiban: new trials by email Literature Review of atosiban trials Research Report on atosiban

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tocolytic Therapy for Preterm Labor in Multiple Gestation
Atosiban, Nifedipine - Labor Preterm Multiple
Phase 3UnknownTel-Aviv Sourasky Medical Center1402016-03-012016-04-01
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
Retosiban, Atosiban, Placebo - Obstetric Labour, Premature
Phase 3CompletedGlaxoSmithKline982015-06-012020-07-09
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour
Retosiban, Atosiban, Placebo matching retosiban - Obstetric Labour, Premature
Phase 3TerminatedGlaxoSmithKline972015-03-162020-07-29
Nifedipine Treatment in Preterm Labor
Nifedipine, Atosiban - Threatened Preterm Labor
Phase 3WithdrawnHospital Clinico Universitario de Santiago2011-07-012014-07-29

Conditions studied

Premature Birth (3)  ·  Obstetric Labor, Premature (1)

Sponsors

GlaxoSmithKline (2)  ·  Hospital Clinico Universitario de Santiago (1)  ·  Tel-Aviv Sourasky Medical Center (1)

Countries

Belgium (2)  ·  Germany (2)  ·  Israel (2)  ·  Italy (2)  ·  Mexico (2)  ·  South Korea (2)  ·  Spain (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Japan (1)  ·  United States (1)

Top investigators

Emilio Cabo Silva, MD (1)  ·  Yariv Yogev, professor (1)

Results publications

PMID 35947046, PMID 34352924

NIH funding

2014 (1)